Fuse Medical Inc
Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company provides orthopedic implants, including internal and external fixation products; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformi… Read more
Fuse Medical Inc (FZMD) - Net Assets
Latest net assets as of June 2023: $-231.63K USD
Based on the latest financial reports, Fuse Medical Inc (FZMD) has net assets worth $-231.63K USD as of June 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($19.32 Million) and total liabilities ($19.55 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-231.63K |
| % of Total Assets | -1.2% |
| Annual Growth Rate | 0.15% |
| 5-Year Change | N/A |
| 10-Year Change | 132949.14% |
| Growth Volatility | 1721.2 |
Fuse Medical Inc - Net Assets Trend (1988–2024)
This chart illustrates how Fuse Medical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Fuse Medical Inc (1988–2024)
The table below shows the annual net assets of Fuse Medical Inc from 1988 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $6.60 Million | +473.94% |
| 2023-12-31 | $1.15 Million | +469.66% |
| 2022-12-31 | $-310.85K | +90.94% |
| 2021-12-31 | $-3.43 Million | -62.43% |
| 2020-12-31 | $-2.11 Million | -72.88% |
| 2019-12-31 | $-1.22 Million | -183.33% |
| 2018-12-31 | $1.47 Million | +118.38% |
| 2017-12-31 | $-7.98 Million | -1871.25% |
| 2016-12-31 | $450.62K | +8990.48% |
| 2015-12-31 | $4.96K | -97.50% |
| 2014-12-31 | $198.50K | -59.04% |
| 2013-12-31 | $484.67K | +1196.79% |
| 2012-12-31 | $-44.19K | -177.00% |
| 2011-12-31 | $57.39K | -97.02% |
| 2010-12-31 | $1.92 Million | -6.16% |
| 2009-12-31 | $2.05 Million | -5.11% |
| 2008-12-31 | $2.16 Million | -3.25% |
| 2007-12-31 | $2.23 Million | -0.84% |
| 2006-12-31 | $2.25 Million | -2.54% |
| 2005-12-31 | $2.31 Million | -4.31% |
| 2004-12-31 | $2.41 Million | -11.32% |
| 2003-12-31 | $2.72 Million | -4.98% |
| 2002-12-31 | $2.87 Million | -6.08% |
| 2001-12-31 | $3.05 Million | -6.28% |
| 2000-12-31 | $3.25 Million | +50.00% |
| 1999-12-31 | $2.17 Million | +3.33% |
| 1997-12-31 | $2.10 Million | +1.94% |
| 1996-12-31 | $2.06 Million | +1.98% |
| 1995-12-31 | $2.02 Million | +2.02% |
| 1993-12-31 | $1.98 Million | -7.48% |
| 1992-12-31 | $2.14 Million | -25.69% |
| 1991-12-31 | $2.88 Million | -45.14% |
| 1990-12-31 | $5.25 Million | -12.65% |
| 1989-12-31 | $6.01 Million | -3.99% |
| 1988-12-31 | $6.26 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Fuse Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 70.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.39 Million | 66.53% |
| Common Stock | $738.96K | 11.20% |
| Other Components | $1.47 Million | 22.26% |
| Total Equity | $6.60 Million | 100.00% |
Fuse Medical Inc Competitors by Market Cap
The table below lists competitors of Fuse Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Impex Ferro Tech Limited
NSE:IMPEXFERRO
|
$550.65K |
|
Ace Integrated Solutions Limited
NSE:ACEINTEG
|
$550.71K |
|
AUBAY
BE:BAQ
|
$551.41K |
|
Netanel Menivim Ltd.
TA:NTNB
|
$551.85K |
|
Alkame Holdings Inc
PINK:ALKM
|
$549.92K |
|
Clubhouse Media Group Inc
PINK:CMGR
|
$549.68K |
|
The Ether Fund
OTCGREY:QETHF
|
$549.37K |
|
Taurus Gold Corp.
PINK:TARGF
|
$548.99K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fuse Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,149,110 to 6,595,246, a change of 5,446,136 (473.9%).
- Net income of 513,960 contributed positively to equity growth.
- Other factors increased equity by 4,932,176.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $513.96K | +7.79% |
| Other Changes | $4.93 Million | +74.78% |
| Total Change | $- | 473.94% |
Book Value vs Market Value Analysis
This analysis compares Fuse Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.06x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.00x to 1.06x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1988-12-31 | $44.79 | $0.09 | x |
| 1989-12-31 | $43.00 | $0.09 | x |
| 1990-12-31 | $37.50 | $0.09 | x |
| 1991-12-31 | $20.57 | $0.09 | x |
| 1992-12-31 | $15.21 | $0.09 | x |
| 1993-12-31 | $14.14 | $0.09 | x |
| 1995-12-31 | $15.46 | $0.09 | x |
| 1996-12-31 | $15.92 | $0.09 | x |
| 1997-12-31 | $16.15 | $0.09 | x |
| 1998-12-31 | $16.54 | $0.09 | x |
| 1999-12-31 | $15.50 | $0.09 | x |
| 2000-12-31 | $17.32 | $0.09 | x |
| 2001-12-31 | $12.94 | $0.09 | x |
| 2002-12-31 | $12.15 | $0.09 | x |
| 2003-12-31 | $11.55 | $0.09 | x |
| 2004-12-31 | $10.24 | $0.09 | x |
| 2005-12-31 | $9.80 | $0.09 | x |
| 2006-12-31 | $9.55 | $0.09 | x |
| 2007-12-31 | $9.47 | $0.09 | x |
| 2008-12-31 | $9.16 | $0.09 | x |
| 2009-12-31 | $8.69 | $0.09 | x |
| 2010-12-31 | $8.16 | $0.09 | x |
| 2011-12-31 | $0.24 | $0.09 | x |
| 2012-12-31 | $-0.18 | $0.09 | x |
| 2013-12-31 | $-0.12 | $0.09 | x |
| 2014-12-31 | $0.05 | $0.09 | x |
| 2015-12-31 | $0.00 | $0.09 | x |
| 2016-12-31 | $0.05 | $0.09 | x |
| 2017-12-31 | $-0.41 | $0.09 | x |
| 2018-12-31 | $0.02 | $0.09 | x |
| 2019-12-31 | $-0.02 | $0.09 | x |
| 2020-12-31 | $-0.03 | $0.09 | x |
| 2021-12-31 | $-0.05 | $0.09 | x |
| 2022-12-31 | $0.00 | $0.09 | x |
| 2023-12-31 | $0.01 | $0.09 | x |
| 2024-12-31 | $0.08 | $0.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fuse Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.79%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.79%
- • Asset Turnover: 0.74x
- • Equity Multiplier: 2.20x
- Recent ROE (7.79%) is above the historical average (-449.31%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1988 | -11.64% | -4.51% | 1.41x | 1.83x | $-1.36 Million |
| 1989 | -2.66% | -1.02% | 1.91x | 1.36x | $-762.00K |
| 1990 | -9.52% | -4.28% | 1.15x | 1.93x | $-1.02 Million |
| 1991 | -82.99% | -23.32% | 1.87x | 1.90x | $-2.68 Million |
| 1992 | -19.25% | -9.51% | 1.80x | 1.12x | $-623.00K |
| 1993 | 4.55% | 0.00% | 0.00x | 1.03x | $-108.00K |
| 1995 | 12.94% | 0.00% | 0.00x | 1.01x | $59.00K |
| 1996 | 12.56% | 866.67% | 0.01x | 1.01x | $53.00K |
| 1997 | 12.38% | 0.00% | 0.00x | 1.00x | $50.00K |
| 1998 | 11.16% | 0.00% | 0.00x | 1.00x | $25.00K |
| 1999 | -9.22% | -2000.00% | 0.00x | 1.00x | $-417.00K |
| 2000 | -15.48% | -50400.00% | 0.00x | 1.01x | $-829.50K |
| 2001 | -6.72% | -130.73% | 0.05x | 1.01x | $-510.05K |
| 2002 | -6.46% | 0.00% | 0.00x | 1.03x | $-471.51K |
| 2003 | -5.24% | 0.00% | 0.00x | 1.02x | $-414.82K |
| 2004 | -15.16% | 0.00% | 0.00x | 1.01x | $-607.57K |
| 2005 | -4.51% | 0.00% | 0.00x | 1.00x | $-335.15K |
| 2006 | -3.91% | 0.00% | 0.00x | 1.00x | $-313.22K |
| 2007 | -1.83% | 0.00% | 0.00x | 1.00x | $-264.13K |
| 2008 | -3.79% | 0.00% | 0.00x | 1.00x | $-297.82K |
| 2009 | -5.38% | 0.00% | 0.00x | 1.00x | $-315.36K |
| 2010 | -8.19% | 0.00% | 0.00x | 1.01x | $-349.84K |
| 2011 | -213.03% | 0.00% | 0.00x | 1.14x | $-128.00K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-97.16K |
| 2013 | 0.00% | -10.37% | 1.98x | 0.00x | $-105.97K |
| 2014 | -707.79% | -149.30% | 1.72x | 2.75x | $-1.42 Million |
| 2015 | -16170.00% | -47.81% | 3.85x | 87.76x | $-802.04K |
| 2016 | 669.31% | 11.75% | 33.46x | 1.70x | $2.97 Million |
| 2017 | 0.00% | 2.65% | 1.37x | 0.00x | $1.50 Million |
| 2018 | 269.86% | 15.03% | 1.19x | 15.12x | $3.81 Million |
| 2019 | 0.00% | -14.48% | 1.25x | 0.00x | $-3.19 Million |
| 2020 | 0.00% | -6.69% | 1.23x | 0.00x | $-1.22 Million |
| 2021 | 0.00% | -7.78% | 1.12x | 0.00x | $-1.24 Million |
| 2022 | 0.00% | 16.62% | 0.94x | 0.00x | $3.13 Million |
| 2023 | 127.05% | 9.06% | 0.99x | 14.15x | $1.35 Million |
| 2024 | 7.79% | 4.79% | 0.74x | 2.20x | $-145.56K |
Industry Comparison
This section compares Fuse Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fuse Medical Inc (FZMD) | $-231.63K | -11.64% | N/A | $550.43K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |